SpotSee, a condition-indicating solutions provider, completed the acquisition of Biosynergy, a manufacturer of medical devices. Financial terms were not disclosed. “This acquisition enables SpotSee to strengthen our mission of reducing damage to products through both the supply and cold chain by adding blood temperature monitoring to our large and growing life science segment. The Biosynergy HemoTemp® brand is a market leader in blood bag monitoring that protects patients from receiving blood that has been exposed to excessive temperature. Its targeted focus and reputation of success makes it a great addition to our temperature-indicating solutions," Tony Fonk, SpotSee CEO.